Clinical Trial

Catecholamine Blockade Post-Burn

Study Description

Catecholamine Blockade Post-burn

Severe burn is associated with a wide array of stress, metabolic, and physiologic processes in an attempt to restore homeostasis. The catecholamine induced stress response following severe burns is particularly exaggerated and manifests detrimentally as inflammation, insulin resistance, hypermetabolism, and associated profound protein catabolism. The investigators hypothesize that catecholamine blockade will lead to restored IR signaling and result in improved post-burn morbidity. The investigators will further determine the molecular mechanisms mediating these effects.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - placebo

identically packed placebo

Drug - propranolol

20-40 mg q6-8h

Additional Information

Official Study Title

Clinical and Molecular Effects of Catecholamine Blockade Post-burn

Clinical Trial ID

NCT01299753

ParticipAid ID

7axvrd